Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 4, 2013, Pages 149-155

  Janda, Katarzyna ^a   Krzanowski, Marcin ^a   Chowaniec, Eve ^a   Kuśnierz Cabala, Beata ^a   Dumnicka, Paulina ^a   Kraśniak, Andrzej ^a   Podolec, Piotr ^a   Sułowicz, Władysław ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bone metabolism parameters; Common carotid artery intima media thickness; Osteoprotegerin; Peritoneal dialysis

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCIUM; FETUIN A; FIBROBLAST GROWTH FACTOR 23; LIPID; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BONE METABOLISM; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PERITONEAL DIALYSIS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84879661933     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1678     Document Type: Article

References (31)

1. de Groot E, Havingh K, Wiegman A, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004; 109: 33-38.
2. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004; 19: 59-66.
3. Lemos MM, Jancikic AD, Sanches FM, et al. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease. Nephron Clin Pract. 2010; 115: 189-194.
4. Stompór T, Rajzer M, Pasowicz M, et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs. 2006; 29: 736-744.
5. Olszanecka A, Pośnik-Urbańska A, Kawecka-Jaszcz K, Czarnecka D. Subclinical organ damage in perimenopausal women with essential hypertension. Pol Arch Med Wewn. 2010; 120: 390-398.
6. Chonchol M, Gnahn H, Sander D. Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly. Nephrol Dial Transplant. 2008; 23: 2593-2598.
7. Ammirati AL, Dalboni MA, Cendoroglo M, et al. The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int. 2007; 27: 340-346.
8. Bevc S, Sabic S, Hojs R, et al. Atherosclerosis in hemodialysis patients - the role of microinflammation. Ren Fail. 2008; 30: 1012-1016.
9. Galli F. Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant. 2007; 22: v20-36.
10. Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest. 2006; 36: 51-62.
11. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
12. Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004; 43: 572-579.
13. Ketteler, Petermann AT. Phosphate and FGF-23 in early CKD: on how to tackle an invisible foe. Nephrol Dial Transplant. 2011; 26: 2430-2432.
14. Parker BD, Schurgers LJ, Brandenburg VM, et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study. Ann Intern Med. 2010; 152: 640-648.
15. Sigrist MK, Levin A, Er L, McIntyre CW. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant. 2009; 24: 3157-3162.
16. Morena M, Terrier N, Jaussent I, et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patient. J Am Soc Nephrol. 2006; 17: 262-270.
17. Nitta K, Akiba T, Uchida K, et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis. 2003; 42: 303-309.
18. Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis. 2009; 204: 321-329.
19. Ketteler M, Bogartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients and dialysis: a cross-sectional study. Lancet. 2003; 361: 827-833.
20. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in gene encoding fetuin. Kidney Int. 2005; 67: 2383-2392.
21. Wang AYM, Woo J, Wai-Kei Lam C, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005; 20: 1676-1685.
22. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94: 45-49.
23. Parker BD, Bauer DC, Ensrud KE, Ix JH. Association of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fractures. Calcif Tissue Int. 2010, 86: 185-191.
24. Negishi K, Kobayashi M, Ochiai I, et al. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T. Circ J. 2010; 74: 2734-2740.
25. Gutiérrez OM, Januzzi JL, Isakova T, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119: 2545-2552.
26. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005; 67; 2295-2304.
27. Wang AY, Ho SS, Liu EK, et al. Differential associations of traditional and non-traditional risk factors with carotid intima-media thickening and plaque in peritoneal dialysis patients. Am J Nephrol. 2007; 27: 458-465.
28. Szeto CC, Chow KM, Woo KS, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol. 2007; 18: 1966-1972.
29. Ito H, Komatsu Y, Mifune M, et al. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2010; 9: 18.
30. Yilmaz MI, Qureshi AR, Carrero JJ, et al. Predictors of carotid intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010; 31: 214-221.
31. Adamczyk T, Mizia-Stec K, Mizia M, et al. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relations to concomitant coronary artery disease. Pol Arch Med Wewn. 2012; 122: 14-21.